A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction
Sunil V. Rao, Bodo Kirsch, Deepak L. Bhatt, Andrzej Budaj et autres
us, de, pl, ca, se, hu, nl, it, es, jp (code pays fourni par la source)